Precision Biosciences (DTIL) EPS (Basic) (2018 - 2026)
Precision Biosciences' (DTIL) quarterly EPS (Basic) came in at -$0.35 in Q1 2026, up 84.8% year-on-year from -$0.19 in Q1 2025, and down 136.03% on a QoQ basis from $0.97 in Q4 2025.
Precision Biosciences (DTIL) EPS (Basic) (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of EPS (Basic) data on file, last reported at -$0.35 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 84.8% year-over-year to -$0.35 in Q1 2026; TTM through Mar 2026 was -$1.87, a 70.6% increase from a year earlier, with the FY2025 full-year figure at $0.07, changed N/A from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.35, down from $0.97 in the prior quarter.
- Over the last five years, EPS (Basic) for DTIL reached as high as $2.23 in Q2 2024 and fell as low as -$16.83 in Q1 2022.
- Historically, EPS (Basic) has averaged -$3.23 across 5 years, with a median of -$2.29 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 195.93% in 2024 and fell as far as 485.05% in 2024.
- Year by year, EPS (Basic) stood at -$3.09 in 2022, then soared by 75.97% to -$0.74 in 2023, then tumbled by 369.64% to -$3.49 in 2024, then surged by 127.68% to $0.97 in 2025, then sank by 136.03% to -$0.35 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.35 in Q1 2026, $0.97 in Q4 2025, and -$2.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 0.00 |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | 0.00 |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 1.55 |
| 10 | Precision Biosciences | 186.98 Mn | 158.68 Mn | - | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | 0.97 |
| Sep 30, 2025 | -2.34 |
| Jun 30, 2025 | -2.01 |
| Mar 31, 2025 | -2.29 |
| Dec 31, 2024 | -3.49 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | 2.23 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | 1.05 |
| Jun 30, 2023 | -2.33 |
| Mar 31, 2023 | -2.99 |
| Dec 31, 2022 | -3.09 |
| Sep 30, 2022 | -2.23 |
| Jun 30, 2022 | -15.83 |
| Mar 31, 2022 | -16.83 |
| Dec 31, 2021 | -15.72 |
| Sep 30, 2021 | -11.13 |
| Jun 30, 2021 | 10.16 |